A large variety of clinical features and concomitant disorders in celiac disease - A cohort study in the Netherlands

Digestive and Liver Disease

Volumn 48, Issue 5, 2016, Pages 499-505

  Spijkerman, Marleen ^a   Tan, Ineke L ^a   Kolkman, Jeroen J ^a,b   Withoff, Sebo ^a   Wijmenga, Cisca ^a   Visschedijk, Marijn C ^a   Weersma, Rinse K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Autoimmune diseases; Coeliac disease; Comorbidity

Indexed keywords

ABDOMINAL CRAMP; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ADULT; APPETITE DISORDER; ARTICLE; AUTOIMMUNE THYROIDITIS; CELIAC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONSTIPATION; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; ERUCTATION; FAILURE TO THRIVE; FATIGUE; FEMALE; FLATULENCE; FOOD REGURGITATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; MOOD CHANGE; NAUSEA; NETHERLANDS; PRIORITY JOURNAL; PUBERTY DISORDERS; SHORT STATURE; STOMATITIS; VOMITING; WEIGHT REDUCTION; AGED; AUTOIMMUNE DISEASES; COLITIS, MICROSCOPIC; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIARRHEA; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; GASTROESOPHAGEAL REFLUX; GRAVES DISEASE; HASHIMOTO DISEASE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDY; YOUNG ADULT;

ABDOMINAL PAIN; ADULT; AGED; AUTOIMMUNE DISEASES; CELIAC DISEASE; COLITIS, MICROSCOPIC; COMORBIDITY; CONSTIPATION; DIABETES MELLITUS, TYPE 1; DIARRHEA; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; FATIGUE; FEMALE; GASTROESOPHAGEAL REFLUX; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NETHERLANDS; PREVALENCE; RETROSPECTIVE STUDIES; WEIGHT LOSS; YOUNG ADULT;

EID: 84957048850     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.01.006     Document Type: Article

References (45)

1. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
2. Di Sabatino A., Corazza G.R. Coeliac disease. Lancet 2009, 373:1480-1493.
3. Mustalahti K., Catassi C., Reunanen A., et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Annals of Medicine 2010, 42:587-595.
4. Guandalini S., Assiri A. Celiac disease: a review. JAMA Pediatrics 2014, 168:272-278.
5. Mooney P.D., Hadjivassiliou M., Sanders D.S. Coeliac disease. British Medical Journal (Clinical Research Edition) 2014, 348.
6. Kelly C.P., Bai J.C., Liu E., et al. Advances in diagnosis and management of celiac disease. Gastroenterology 2015.
7. Green P.H.R. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005, 128.
8. Dewar D.H., Ciclitira P.J. Clinical features and diagnosis of celiac disease. Gastroenterology 2005, 128.
9. Gujral N., Freeman H.J., Thomson A.B. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World Journal of Gastroenterology 2012, 18:6036-6059.
10. Tack G.J., Verbeek W.H., Schreurs M.W., et al. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nature Reviews Gastroenterology & Hepatology 2010, 7:204-213.
11. Lauret E., Rodrigo L. Celiac disease and autoimmune-associated conditions. BioMed Research International 2013, 2013:127589.
12. Diamanti A., Capriati T., Bizzarri C., et al. Celiac disease and endocrine autoimmune disorders in children: an update. Expert Review of Clinical Immunology 2013, 9:1289-1301.
13. Green P.H.R., Aaron T.F., Bhagat G., et al. Risk of malignancy in patients with celiac disease. American Journal of Medicine 2003, 115.
14. Grainge M.J., West J., Solaymani-Dodaran M., et al. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Alimentary Pharmacology and Therapeutics 2012, 35:730-739.
15. Tio M., Cox M.R., Eslick G.D. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Alimentary Pharmacology and Therapeutics 2012, 35:540-551.
16. Ilus T., Kaukinen K., Virta L.J., et al. Incidence of malignancies in diagnosed celiac patients: a population-based estimate. American Journal of Gastroenterology 2014, 109:1471-1477.
17. West J., Logan R.F., Smith C.J., et al. Malignancy and mortality in people with coeliac disease: population based cohort study. British Medical Journal (Clinical Research Edition) 2004, 329:716-719.
18. Ludvigsson J.F., Ludvigsson J., Ekbom A. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 2006.
19. Lo W., Sano K., Lebwohl B., et al. Changing presentation of adult celiac disease. Digestive Diseases and Sciences 2003, 48:395-398.
20. Bai D., Brar P., Holleran S., et al. Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scandinavian Journal of Gastroenterology 2005, 40:183-187.
21. Rampertab S., Pooran N., Brar P., et al. Trends in the presentation of celiac disease. American Journal of Medicine 2006, 119.
22. Volta U., Caio G., Stanghellini V., et al. The changing clinical profile of celiac disease: a 15-year experience (1998-2012) in an Italian referral center. BMC Gastroenterology 2014, 14:194.
23. Dickson B.C., Streutker C.J., Chetty R. Coeliac disease: an update for pathologists. Journal of Clinical Pathology 2006, 59:1008-1016.
24. Hoffmann J.J.M.L. Hematologie 1998, Bohn Stafleu Van Loghum, Houten.
25. Mooney P.D., Leeds J.S., Libzo N., et al. Case-finding for coeliac disease in secondary care: a prospective multicentre UK study. Digestive and Liver Disease 2014, 46:32-35.
26. Thomas H.J., Ahmad T., Rajaguru C., et al. Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scandinavian Journal of Gastroenterology 2009, 44:1076-1083.
27. Burger J.P., Roovers E.A., Drenth J.P., et al. Rising incidence of celiac disease in the Netherlands; an analysis of temporal trends from 1995 to 2010. Scandinavian Journal of Gastroenterology 2014, 49:933-941.
28. Ciacci C., Cirillo M., Sollazzo R., et al. Gender and clinical presentation in adult celiac disease. Scandinavian Journal of Gastroenterology 1995.
29. Mooney P.D., Evans K.E., Kurien M. Gastro-oesophageal reflux symptoms and coeliac disease: no role for routine duodenal biopsy. European Journal of Gastroenterology and Hepatology 2015, 13:1278-1284.
30. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nature Reviews: Genetics 2009, 10:43-55.
31. Neuhausen S.L., Steele L., Ryan S., et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. Journal of Autoimmunity 2008, 31:160-165.
32. Kumar V., Wijmenga C., Withoff S. From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Seminars in Immunopathology 2012, 34:567-580.
33. Garner C., Ahn R., Yuan C.D., et al. Genome-wide association study of celiac disease in North America confirms FRMD4B as new celiac locus. PLOS ONE 2014, 9.
34. Peter H.R.G., Yang J., Cheng J., et al. An association between microscopic colitis and celiac disease. Clinical Gastroenterology and Hepatology 2009.
35. Stewart M., Andrews C.N., Urbanski S., et al. The association of coeliac disease and microscopic colitis: a large population-based study. Alimentary Pharmacology and Therapeutics 2011.
36. Ventura A., Magazzù G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999, 117:297-303.
37. C SG., Solerio E., Scaglione N., et al. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 2001, 49.
38. Card T.R., West J., Holmes G.K. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Alimentary Pharmacology and Therapeutics 2004, 20:769-775.
39. Siesling S.S., Sonke G.S., de Raaf D.H.A., et al. Kankerzorg in beeld 2014, Integraal kankercentrum Nederland, The Netherlands.
40. Verbeek W.H., Water V.D., Al-Toma A., et al. Incidence of enteropathy-associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands. Scandinavian Journal of Gastroenterology 2008, 43:1322-1328.
41. Catassi C., Bearzi I., Holmes G.K.T. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005, 128.
42. Green P.H.R., Stavropoulos S.N., Panagi S.G., et al. Characteristics of adult celiac disease in the USA: results of a national survey. American Journal of Gastroenterology 2001, 96:126-131.
43. Li Q., Withoff S., Verma I.M. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends in Immunology 2005, 26:318-325.
44. Kiraly O., Gong G., Olipitz W., et al. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genetics 2015, 11.
45. Grivennikov S., Greten F., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140.